The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2017

Filed:

May. 07, 2015
Applicant:

Batu Biologics, San Diego, CA (US);

Inventors:

Samuel C. Wagner, San Diego, CA (US);

Andy J. Kim, San Diego, CA (US);

Dimitri N. Theofilopoulos, San Diego, CA (US);

Brandon R. Dolan, San Diego, CA (US);

Naseem Ajili, Laguna Niguel, CA (US);

Assignee:

Batu Biologics, San Diego, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/375 (2006.01); A61K 9/00 (2006.01); A61K 31/355 (2006.01); A61K 31/4745 (2006.01); A61K 38/20 (2006.01); A61K 31/437 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/375 (2013.01); A61K 9/0019 (2013.01); A61K 31/355 (2013.01); A61K 31/437 (2013.01); A61K 31/4745 (2013.01); A61K 38/2013 (2013.01); A61K 45/06 (2013.01);
Abstract

The current application teaches methods and compositions useful for the treatment of cancer through administration of an antioxidant together with an immune stimulator at concentrations sufficient to augment antitumor immunity while simultaneously preventing inhibition of T cell function as a result of tumor secreted oxidative stress. Compositions such as toll like receptor agonists in combination with antioxidants are disclosed. In further embodiments, the application teaches the use of antioxidants to prevent immunotherapy associated oxidative stress, of which, one manifestation is vascular leak syndrome. In one specific embodiment, the application teaches the use of intravenous ascorbic acid as a means of reducing IL-2 associated toxicity.


Find Patent Forward Citations

Loading…